Sign In
Buy NVS
$153.38
+4.45 (+2.99%)
At Close: Jun 23, 2026
Novartis (NVS) Gets Positive CHMP Opinion for Scemblix in CML
01:50pm, Monday, 27'th Jun 2022
The CHMP recommends approval of Novartis' (NVS) Scemblix for treating adult patients with chronic myeloid leukemia. EU also approves label expansion of Cosentyx.
Cheap Stocks To Buy Today? 3 Health Care Stocks For Your Watchlist
12:30pm, Monday, 27'th Jun 2022
While individuals are fearing another pandemic, could health care stocks be a great addition to your watchlist?
Pharma Stock Roundup: FDA OK's Expanded Use of ABBV, MRK, NVS Drugs, Other Updates
01:19pm, Friday, 24'th Jun 2022 Zacks Investment Research
The FDA approves expanded use of AbbVie's (ABBV) Skyrizi, Merck's (MRK) Vaxneuvance vaccine and Novartis's (NVS) cancer combination drugs, Tafinlar (dabrafenib) + Mekinist (trametinib).
Novartis' (NVS) Oncology Drugs Get Approval for Label Expansion
04:37pm, Thursday, 23'rd Jun 2022 Zacks Investment Research
Novartis (NVS) obtains regulatory approval for label expansion of Tafinlar + Mekinist and Tabrecta.
Precision BioSciences' (DTIL) Stock Up This Week: Here's Why
04:08pm, Thursday, 23'rd Jun 2022 Zacks Investment Research
Shares of Precision BioSciences (DTIL) are up as the company inks a gene-editing deal with Novartis to develop a potentially curative treatment for disorders like sickle cell disease.
Novartis' (NVS) Oncology Drugs Get Approval for Label Expansion
01:54pm, Thursday, 23'rd Jun 2022
Novartis (NVS) obtains regulatory approval for label expansion of Tafinlar + Mekinist and Tabrecta.
Why These 5 European Dividend Aristocrats (Some With Huge Yields) Are Incredible Q3 Buys
07:35am, Thursday, 23'rd Jun 2022
Well, that didn't last long. As we suspected, each and every market rally until the Federal Reserve completes the interest rate hike cycle likely will be met with selling as investors try to go to cas
Precision BioSciences (DTIL) Stock Treks Higher on Novartis Deal
10:25am, Wednesday, 22'nd Jun 2022
DTIL stock is advancing in early trading today after Precision BioScience announced a partnership with Novartis, a leading drug maker. The post Precision BioSciences (DTIL) Stock Treks Higher on Novar
Ionis (IONS), AstraZeneca's Amyloidosis Drug Meets Study Goals
01:32pm, Tuesday, 21'st Jun 2022 Zacks Investment Research
Ionis (IONS), along with partner AstraZeneca, reports positive data from a phase III study, which is evaluating eplontersen in hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN).
My, Oh, My 11 Incredible High-Yield Dividend Aristocrat Bear Market Buys
04:00pm, Saturday, 18'th Jun 2022 Seeking Alpha
This bear market is the 2nd worst start to the year in US stock market history. Fortunately, the world's best high-yield blue-chips are ready to protect your hard-earned savings.
My, Oh, My 11 Incredible High-Yield Dividend Aristocrat Bear Market Buys
12:00pm, Saturday, 18'th Jun 2022
This bear market is the 2nd worst start to the year in US stock market history. And cracks are beginning to form in credit markets that could potentially send stocks falling even lower in the coming m
7 High-Yield Retirement Dream Blue-Chip Buys
02:00pm, Wednesday, 15'th Jun 2022 Seeking Alpha
VFC, NVS, CSCO, ALIZY, MMM, EPD, & MO represent 7 of the world's safest dividend blue-chips in 7 sectors that create a diverse stock portfolio. See more here.
What Could a Recession Mean for Healthcare Stocks?
03:30pm, Thursday, 09'th Jun 2022 The Motley Fool
It depends on which subsector you're talking about.
What Could a Recession Mean for Healthcare Stocks?
11:30am, Thursday, 09'th Jun 2022
It depends on which subsector you're talking about.
3 Great Dividend Stocks to Buy in June
11:04am, Sunday, 05'th Jun 2022 The Motley Fool
Investors should be able to count on recurring income with these stocks.
